Drug
Pxvx0200 10e8
Pxvx0200 10e8: highest development phase Phase 2, developed by Emergent BioSolutions. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| PXVX0200 10E8 NCT02145377 | Phase 2 | Cholera |
Latest
No recent events.
Follow Pxvx0200 10e8 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.